277 related articles for article (PubMed ID: 28501127)
1. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
[TBL] [Abstract][Full Text] [Related]
2. C-C motif chemokine ligand 5 (CCL5) levels in gastric cancer patient sera predict occult peritoneal metastasis and a poorer prognosis.
Wang T; Wei Y; Tian L; Song H; Ma Y; Yao Q; Feng M; Wang Y; Gao M; Xue Y
Int J Surg; 2016 Aug; 32():136-42. PubMed ID: 27398691
[TBL] [Abstract][Full Text] [Related]
3. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.
Choi SR; Jang JS; Lee JH; Roh MH; Kim MC; Lee WS; Qureshi W
Dig Dis Sci; 2006 Nov; 51(11):2081-6. PubMed ID: 17009116
[TBL] [Abstract][Full Text] [Related]
4. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
[TBL] [Abstract][Full Text] [Related]
5. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
6. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
7. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
8. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
9. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
11. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
12. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
Li F; Zhang R; Liang H; Liu H; Quan J
J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
14. Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Baiocchi GL; Marrelli D; Verlato G; Morgagni P; Giacopuzzi S; Coniglio A; Marchet A; Rosa F; Capponi MG; Di Leo A; Saragoni L; Ansaloni L; Pacelli F; Nitti D; D'Ugo D; Roviello F; Tiberio GA; Giulini SM; De Manzoni G
Ann Surg Oncol; 2014 Jun; 21(6):2005-11. PubMed ID: 24526547
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
16. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis.
Saito H; Kihara K; Kuroda H; Matsunaga T; Tatebe S; Ikeguchi M
J Surg Oncol; 2011 Oct; 104(5):534-7. PubMed ID: 21618248
[TBL] [Abstract][Full Text] [Related]
17. Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence.
Ohashi T; Komatsu S; Ichikawa D; Kosuga T; Okamoto K; Arita T; Konishi H; Morimura R; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
Int J Clin Oncol; 2017 Oct; 22(5):897-904. PubMed ID: 28488013
[TBL] [Abstract][Full Text] [Related]
18. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer.
Hu XY; Ling ZN; Hong LL; Yu QM; Li P; Ling ZQ
J Clin Lab Anal; 2021 Sep; 35(9):e23936. PubMed ID: 34390026
[TBL] [Abstract][Full Text] [Related]
19. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
